Medicare Enrolled
Douglas Hogarth
Pulmonary Disease · Chicago, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Hogarth from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Hogarth?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Hogarth
Douglas Hogarth is a pulmonary disease specialist in Chicago, IL, with 19 years of NPI registration. Based on federal Medicare data, Hogarth performed 640 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Hogarth received a total of $2,697,874 from 55 pharmaceutical and/or device companies across 2901 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Hogarth is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 640 Medicare services
$2,697,874 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗640
Medicare services
Bottom 41% in IL for pulmonary disease
Not available
Unique patients (not deduplicated)
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
230 | $52 | $243 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $108 | $581 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
58 | $114 | $4,122 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
54 | $60 | $3,531 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
51 | $82 | $942 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
39 | $44 | $3,122 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
27 | $209 | $3,706 |
| Bronchial valve insertion for lung air leak A procedure using an endoscope to insert a valve into the lung airway to assess for air leaks and determine airway size. |
21 | $174 | $8,343 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
20 | $91 | $1,032 |
| Placement of radiation therapy markers in lung airways A procedure where small markers are placed into the airways of the lung using an endoscope to assist with radiation therapy targeting. |
19 | $94 | $942 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
14 | $57 | $996 |
| Abdominal fluid drainage with imaging guidance Removal of fluid from the abdominal cavity using imaging technology to guide the procedure. |
14 | $88 | $2,251 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
13 | $137 | $3,353 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
3.3% high complexity
34.2% medium
62.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,697,874
Total received (2018-2024)
Avg $385,411/year across 7 years
Top 0% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
2,901
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$443,525
2023
$410,774
2022
$436,781
2021
$306,802
2020
$184,622
2019
$673,085
2018
$242,285
Payments by company (2024)
Noah Medical Corporation
$170,610
AstraZeneca Pharmaceuticals LP
$163,913
Takeda Pharmaceuticals U.S.A., Inc.
$44,401
Grifols USA, LLC
$30,688
Pulmonx Corporation
$22,604
Olympus America Inc.
$5,580
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,040
Regeneron Healthcare Solutions, Inc.
$168
Boston Scientific Corporation
$123
4DMedical USA Inc
$115
GlaxoSmithKline, LLC.
$70
Genentech USA, Inc.
$65
Amgen Inc.
$64
United Therapeutics Corporation
$58
Regeneron Pharmaceuticals, Inc.
$18
Body Vision Medical Inc.
$10
Top 3 companies account for 85.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$770,347
Ethicon Inc.
$558,954
Noah Medical Corporation
$291,574
Grifols USA, LLC
$283,796
Takeda Pharmaceuticals U.S.A., Inc.
$166,455
Pulmonx Corporation
$138,003
Boehringer Ingelheim Pharmaceuticals, Inc.
$86,232
Boston Scientific Corporation
$83,365
Amgen Inc.
$46,127
Ambu A/S
$45,624
Ethicon Endo-Surgery Inc.
$35,207
Shire North American Group Inc
$32,368
Olympus America Inc.
$25,136
Genentech USA, Inc.
$23,587
Covidien LP
$18,863
Auris Health, Inc.
$16,464
BOSTON SCIENTIFIC CORPORATION
$14,162
Medical Device Business Services, Inc.
$8,790
IsoRay, Inc
$6,860
GENZYME CORPORATION
$6,672
Gyrus ACMI, Inc.
$5,940
Imbio Inc.
$5,682
GlaxoSmithKline, LLC.
$4,622
Regeneron Healthcare Solutions, Inc.
$4,363
Broncus Medical
$4,327
Acerta Pharma LLC
$2,292
Spiration, Inc.
$1,615
Ambu Inc.
$1,443
Olympus Corporation of the Americas
$1,320
Body Vision Medical Inc.
$1,319
Veran Medical Technologies, Inc.
$1,112
AstraZeneca UK Limited
$1,074
Mauna Kea Technologies, Inc.
$931
CSL Behring
$873
Galvanize Therapeutics, Inc
$593
Intuitive Surgical, Inc.
$499
Medtronic, Inc.
$246
Pinnacle Biologics, Inc
$211
4DMedical USA Inc
$115
Janssen Research & Development, LLC
$113
SANOFI-AVENTIS U.S. LLC
$100
Philips Electronics North America Corporation
$97
Novartis Pharmaceuticals Corporation
$82
United Therapeutics Corporation
$58
PFIZER INC.
$51
Janssen Biotech, Inc.
$37
Cook Medical LLC
$33
Mylan Specialty L.P.
$33
Teva Pharmaceuticals USA, Inc.
$24
Horizon Therapeutics plc
$21
Regeneron Pharmaceuticals, Inc.
$18
ABBVIE INC.
$14
AbbVie, Inc.
$13
Genentech, Inc.
$13
Grifols Shared Services North America, Inc.
$2
Top 3 companies account for 60.1% of all-time payments
Associated products mentioned in payments ›
(5028) IGT D Systems Und · (9547) IGT Systems Und · 1.8mm OD · 120V · 60Hz · ACQUIRE · AIRSUPRA · ALAIR · ALAIR BRONCHIAL THERMOPLASTY SYSTEM · ALIYA SYSTEM · ANORO · ARALAST · Acquire · Actemra · Always-On Tip Tracked Forceps · BREO · BREZTRI · BREZTRI AEROSPHERE · Brachytherapy Source · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHARTIS CATHETER · CINQAIR · CREON · CT LVAS · CUVITRU · Clinical Trial Product · CoreDx · Creon · DUPIXENT · Da Vinci Surgical System · ENDOCAPSULE SMALL INTESTINAL CAPSULE ENDOSCOPE SET?? · EXALT · EXALT BX 2 · EXALT BX 4 · EXALT Model D · EXCELON · EXPECT · Expect · FASENRA · GALAXY · GENERAL PULMONARY · GENERAL PULMONARY · GENERAL THERAPIES · GENERAL - PULMONARY · GENERAL BRONCHIAL THERMOPLASTY · GENERAL PAIN MANAGEMENT · GENERAL PULMONARY · GENERAL THERAPIES · GLASSIA · Gamunex-C · General - Pulmonary · General - Therapies · HYQVIA · ILLUMISITE · IMFINZI · Imbio Lung Density Analysis · KEVZARA · KRYSTEXXA · LungVision · MONARCH · Monarch · Monarch Platform · NAVIGATION · NEUWAVE Flex Microwave Ablation System · NUCALA · Olympus Respiratory Accessories · PREVNAR - 13 · PREVNAR 13 · Photofrin · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Respiratory Core Devices · SPIRIVA · SPYSCOPE · SPiN Thoracic Navigation System · STELARA · STIOLTO RESPIMAT · SVS · SYMBICORT · Serrated Cup · Single-Use flexible Video Bronchoscope · Spin · Spiration Valve System · SuperDimension · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · ULTRAFLEX · WAYNE · XOLAIR · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE · Zemaira · superDimension
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
231
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
THE UNIVERSITY OF CHICAGO MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Hogarth is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Hogarth experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Hogarth performed 230 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Hogarth receive payments from pharmaceutical companies?
Yes. Hogarth received a total of $2,697,874 from 55 companies across 2,901 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Hogarth's costs compare to other pulmonary diseases in Chicago?
Hogarth's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Hogarth) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Chicago
Browse pulmonary diseases in Chicago ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in IL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in IL
Which IL pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Ethicon Inc. Payments to Doctors
See all physicians who received payments from Ethicon Inc.
By company
Noah Medical Corporation Payments to Doctors
See all physicians who received payments from Noah Medical Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology